PDC line Pharma

{
  "events": [
    {
      "kind": "zetel_transfer",
      "seat_type": "statutaire",
      "new_address": {
        "city": "LIEGE",
        "region": "Brussels Gewest",
        "street": "Boulevard Patience et Beaujonc",
        "country": "BE",
        "postcode": "4000",
        "box_number": "6",
        "street_number": "3"
      },
      "old_address": {
        "city": "Li\u00E8ge",
        "region": "Waals",
        "street": "rue Louvrex",
        "country": "BE",
        "postcode": "4000",
        "box_number": "57",
        "street_number": "55"
      },
      "effective_date": "2025-10-22",
      "evidence_quote": "Par jugement du 22 octobre 2025, le Tribunal de l\u0027entreprise de Li\u00E8ge - division Li\u00E8ge a homologu\u00E9 le transfert du si\u00E8ge de la soci\u00E9t\u00E9 PDC LINE en liquidation au cabinet du liquidateur situ\u00E9 \u00E0 4000 Li\u00E8ge, rue Louvrex, 55/57."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0657.842.221",
    "name_full": "PDC LINE PHARMA",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "vereffenaar",
      "person": {
        "rrn": null,
        "name": "Ma\u00EEtre Romany AYDOGDU",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2025-06-30",
      "evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide de nommer en tant que liquidateur pour une dur\u00E9e ind\u00E9termin\u00E9e: Ma\u00EEtre Romany AYDOGDU, avocat associ\u00E9 au sein du cabinet MOSAL, \u00E9tabli \u00E0 4000 Li\u00E8ge, Rue Louvrex 55."
    },
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "administrateurs en fonction",
        "address": null,
        "birth_date": null
      },
      "evidence_quote": "La dissolution met fin de plein droit aux mandats des administrateurs en fonction. L\u0027assembl\u00E9e g\u00E9n\u00E9rale leur donne d\u00E9charge pour l\u0027exercice de leur mandat pendant l\u0027exercice social en cours, mais sous r\u00E9serve de ce qui pourrait appara\u00EEtre du rapport du liquidateur, comme pouvant \u00EAtre mis \u00E0 leur char",
      "discharge_granted": true
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0657.842.221",
    "name_full": "PDC LINE PHARMA",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Patrick STRAGIER",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0657842221",
        "name": "S.R.L. NOSHAQ PARTNERS",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "Par un courrier du 17 mai 2024 adress\u00E9 au Conseil d\u0027administration de la S.A. PDC LINE PHARMA, la S.R.L. NOSHAQ PARTNERS a inform\u00E9 la soci\u00E9t\u00E9 du remplacement de son repr\u00E9sentant permanent, MadMonsieur Patrick STRAGIER, par Madame Marleen LIMBOURG, avec effet imm\u00E9diat."
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Marleen LIMBOURG",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0657842221",
        "name": "S.R.L. NOSHAQ PARTNERS",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "Par un courrier du 17 mai 2024 adress\u00E9 au Conseil d\u0027administration de la S.A. PDC LINE PHARMA, la S.R.L. NOSHAQ PARTNERS a inform\u00E9 la soci\u00E9t\u00E9 du remplacement de son repr\u00E9sentant permanent, MadMonsieur Patrick STRAGIER, par Madame Marleen LIMBOURG, avec effet imm\u00E9diat."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0657.842.221",
    "name_full": "PDC LINE PHARMA",
    "legal_form": "SA"
  }
}

{
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "statute_change": {
    "name_change": false,
    "seat_change": false,
    "object_change": false,
    "effective_date": "2023-12-15",
    "legal_form_change": false
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0657.842.221",
    "name_full": "PDC LINE PHARMA",
    "legal_form": "SA"
  },
  "signature_regime": null,
  "special_mandates": [
    {
      "quote": "au notaire soussign\u00E9 aux fins de proc\u00E9der \u00E0 la publication du pr\u00E9sent proc\u00E8s-verbal aux Annexes du Moniteur belge et pour l\u2019\u00E9tablissement d\u2019une version coordonn\u00E9e des statuts. A ces fins, chaque mandataire pourra au nom de la soci\u00E9t\u00E9, faire toutes d\u00E9clarations, signer tous documents et pi\u00E8ces et, en g\u00E9n\u00E9ral, faire le n\u00E9cessaire.",
      "holder_kbo": null,
      "holder_name": "Ma\u00EEtre G\u00E9rard INDEKEU",
      "scope_categories": [
        "publication",
        "filing"
      ],
      "with_substitution": true
    }
  ],
  "governance_change": {
    "admin_delegated_added": []
  }
}

{
  "stage": null,
  "notary": {
    "name": "G\u00E9rard INDEKEU",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Bruxelles",
    "is_associated": false
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2024-01-11",
    "filing_date": "2024-01-09",
    "act_kind_objet": "DIVERS"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2023-09-08",
    "unanimous": true
  },
  "conversion": null,
  "detected_kind": "other",
  "report_waiver": null,
  "restructuring": {
    "parties": [
      {
        "kbo": "0657.842.221",
        "name": "PDC line Pharma",
        "role": "other",
        "address": "Boulevard de Patience et Beaujonc 3 bte 6, 4000 Li\u00E8ge",
        "is_foreign": false,
        "legal_form": "Soci\u00E9t\u00E9 anonyme",
        "is_new_company": false,
        "jurisdiction_country": "BE"
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [],
    "is_cross_border": false,
    "is_silent_merger": false,
    "balance_basis_date": "2022-12-31",
    "exchange_ratio_text": null,
    "new_shares_issued_n": null,
    "real_estate_included": false,
    "patrimony_description": "La r\u00E9duction du compte \u0027Primes d\u0027\u00E9mission\u0027 est effectu\u00E9e par apurement des pertes report\u00E9es, conform\u00E9ment aux comptes annuels cl\u00F4tur\u00E9s le 31 d\u00E9cembre 2022.",
    "equity_transferred_eur": null,
    "accounting_effective_date": null
  },
  "subject_company": {
    "kbo": "0657.842.221",
    "name_full": "PDC line Pharma",
    "legal_form": "Soci\u00E9t\u00E9 anonyme"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "G\u00E9rard INDEKEU",
    "org_rep_person_name": null
  },
  "summary_narrative": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale extraordinaire des actionnaires de PDC line Pharma, soci\u00E9t\u00E9 anonyme inscrite au registre des personnes morales sous le num\u00E9ro 0657.842.221, s\u0027est tenue le 8 septembre 2023. \u00C0 l\u0027unanimit\u00E9, elle a d\u00E9cid\u00E9 de r\u00E9duire le compte \u00AB Primes d\u0027\u00E9mission \u00BB de 24.124.133,00 \u20AC \u00E0 4.999.029,91 \u20AC par apurement des pertes report\u00E9es, telles qu\u0027elles figurent dans les comptes annuels cl\u00F4tur\u00E9s le 31 d\u00E9cembre 2022. L\u0027assembl\u00E9e a \u00E9galement attribu\u00E9 tous pouvoirs \u00E0 l\u0027administrateur-d\u00E9l\u00E9gu\u00E9 et au notaire pour les d\u00E9marches administratives et la publication du proc\u00E8s-verbal.",
  "co_filed_documents": [
    "exp\u00E9dition conforme de l\u0027acte",
    "liste de pr\u00E9sences"
  ],
  "detected_real_type": "other",
  "referenced_correction": null,
  "should_reroute_to_category": "statutes"
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "NOSHAQ PARTNERS",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2023-11-15",
      "evidence_quote": "la S.R.L. NOSHAQ PARTNERS a inform\u00E9 la soci\u00E9t\u00E9 du remplacement de son repr\u00E9sentant permanent, Madame Amel TOUNSI, par Monsieur Patrick STRAGIER, avec effet imm\u00E9diat."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0657.842.221",
    "name_full": "PDC LINE PHARMA",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "capital_decrease",
      "amount": 3237781.8,
      "currency": "EUR",
      "after_eur": 4000000.0,
      "delta_eur": -3237781.8,
      "before_eur": 7237781.8,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2023-05-23",
      "evidence_quote": "L\u2019assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide de r\u00E9duire le capital \u00E0 concurrence de trois millions deux cent trente-sept mille sept cent quatre-vingt-un euros quatre-vingt cents (3.237.781,80 \u20AC) pour le porter de sept millions deux cent trente-sept mille sept cent quatre-vingt-un euros et quatre-vingt centimes (7.237.781,80 \u20AC) \u00E0 quatre millions d\u2019euros (4.000.000,00 \u20AC)",
      "contribution_type": null
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0657.842.221",
    "name_full": "PDC LINE PHARMA",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "zetel_transfer",
      "seat_type": "statutaire",
      "new_address": {
        "city": "Li\u00E8ge",
        "region": null,
        "street": "Boulevard Patience et Beaujonc",
        "country": "BE",
        "postcode": "4000",
        "box_number": "6",
        "street_number": "3"
      },
      "old_address": {
        "city": "Li\u00E8ge",
        "region": null,
        "street": "avenue de l\u0027H\u00F4pital",
        "country": "BE",
        "postcode": "4000",
        "box_number": "34",
        "street_number": "11"
      },
      "effective_date": "2023-07-01",
      "evidence_quote": "Les administrateurs d\u00E9cident de transf\u00E9rer le si\u00E8ge social de la Soci\u00E9t\u00E9 \u00E0 l\u0027adresse suivante, avec effet au 1er juillet 2023: Boulevard Patience et Beaujonc n\u00B03 bo\u00EEte 6 4000 Li\u00E8ge"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0657.842.221",
    "name_full": "PDC LINE PHARMA",
    "legal_form": "SA"
  }
}

{
  "stage": null,
  "notary": {
    "name": "G\u00E9rard INDEKEU",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Bruxelles",
    "is_associated": false
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2023-03-22",
    "filing_date": "2023-03-20",
    "act_kind_objet": "DIVERS"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2023-02-07",
    "unanimous": true
  },
  "conversion": null,
  "detected_kind": "other",
  "report_waiver": null,
  "restructuring": null,
  "subject_company": {
    "kbo": "0657.842.221",
    "name_full": "PDC line Pharma",
    "legal_form": "Soci\u00E9t\u00E9 anonyme"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "G\u00E9rard INDEKEU",
    "org_rep_person_name": null
  },
  "summary_narrative": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale extraordinaire des actionnaires de PDC line Pharma, soci\u00E9t\u00E9 anonyme inscrite au registre des personnes morales sous le num\u00E9ro 0657.842.221, s\u0027est r\u00E9unie le 7 f\u00E9vrier 2023. \u00C0 l\u0027unanimit\u00E9, elle a confirm\u00E9 la prolongation de la dur\u00E9e des 11.450 droits de souscription attribu\u00E9s en 2019, les a red\u00E9finis en mati\u00E8re de b\u00E9n\u00E9ficiaires, Good Leaver et Bad Leaver, et a modifi\u00E9 les p\u00E9riodes de vesting et d\u0027exercice des options sur actions dans les plans SOP 2019, 2020 et 2021. Elle a \u00E9galement attribu\u00E9 des pouvoirs \u00E0 l\u0027administrateur-d\u00E9l\u00E9gu\u00E9 et au notaire pour les d\u00E9marches administra",
  "co_filed_documents": [
    "exp\u00E9dition conforme de l\u0027acte",
    "liste de pr\u00E9sences"
  ],
  "detected_real_type": "other",
  "referenced_correction": null,
  "should_reroute_to_category": "statutes"
}

{
  "events": [
    {
      "kind": "commissaris_out",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Abdel Serghini",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "L\u0026S R\u00E9viseurs d\u0027Entreprises SRL",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "Par r\u00E9solution prise \u00E0 l\u0027unanimit\u00E9 lors de l\u0027Assembl\u00E9e G\u00E9n\u00E9rale du 19 mai 2022, il a \u00E9t\u00E9 pris acte de la d\u00E9mission de L\u0026S R\u00E9viseurs d\u0027Entreprises SRL, repr\u00E9sent\u00E9e par Abdel Serghini, r\u00E9viseur, de son mandat de Commissaire."
    },
    {
      "kind": "commissaris_in",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Patrick Mortroux",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "SCRL PwC Reviseurs d\u0027Entreprises",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "L\u0027assembl\u00E9e a d\u00E9cid\u00E9 de nommer la SCRL PwC Reviseurs d\u0027Entreprises, repr\u00E9sent\u00E9e par Patrick Mortroux, r\u00E9viseur, en tant que nouveau Commissaire aux comptes;"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0657.842.221",
    "name_full": "PDC LINE PHARMA",
    "legal_form": "SA"
  }
}

{
  "stage": null,
  "notary": {
    "name": "G\u00E9rard INDEKEU",
    "firm_city": null,
    "firm_name": "G\u00E9rard INDEKEU - Dimitri CLEENEWERCK de CRAYENCOUR",
    "office_city": "Bruxelles",
    "is_associated": true
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2022-06-01",
    "filing_date": "2022-05-30",
    "act_kind_objet": "DIVERS"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2022-05-19",
    "unanimous": true
  },
  "conversion": null,
  "detected_kind": "other",
  "report_waiver": null,
  "restructuring": {
    "parties": [
      {
        "kbo": "0657.842.221",
        "name": "PDC line Pharma",
        "role": "other",
        "address": "Avenue de l\u0027H\u00F4pital 11, 4000 Li\u00E8ge",
        "is_foreign": false,
        "legal_form": "Soci\u00E9t\u00E9 anonyme",
        "is_new_company": false,
        "jurisdiction_country": "BE"
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [],
    "is_cross_border": false,
    "is_silent_merger": false,
    "balance_basis_date": null,
    "exchange_ratio_text": null,
    "new_shares_issued_n": null,
    "real_estate_included": false,
    "patrimony_description": "La prolongation de la dur\u00E9e des droits de souscription (\u00AB stock options \u00BB) \u00E9mis le 12 septembre 2019, sans transfert de patrimoine ni modification de la structure soci\u00E9taire.",
    "equity_transferred_eur": null,
    "accounting_effective_date": null
  },
  "subject_company": {
    "kbo": "0657.842.221",
    "name_full": "PDC line Pharma",
    "legal_form": "Soci\u00E9t\u00E9 anonyme"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "G\u00E9rard INDEKEU",
    "org_rep_person_name": null
  },
  "summary_narrative": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale extraordinaire de la soci\u00E9t\u00E9 anonyme PDC line Pharma, r\u00E9unie le 19 mai 2022, a d\u00E9cid\u00E9 \u00E0 l\u0027unanimit\u00E9 de prolonger la dur\u00E9e des droits de souscription \u00E9mis le 12 septembre 2019, passant de 5 \u00E0 10 ans, conform\u00E9ment aux dispositions du Plan SOP 2019. Aucune modification du patrimoine ou de la structure soci\u00E9taire n\u0027est op\u00E9r\u00E9e. Les pouvoirs sont attribu\u00E9s \u00E0 l\u0027administrateur-d\u00E9l\u00E9gu\u00E9 et au notaire pour les d\u00E9marches administratives et de publication.",
  "co_filed_documents": [
    "exp\u00E9dition conforme de l\u0027acte",
    "liste de pr\u00E9sence",
    "procurations"
  ],
  "detected_real_type": "other",
  "referenced_correction": null,
  "should_reroute_to_category": "statutes"
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Eric HALIOUA",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0811816556",
        "name": "CARKATH",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "3) la soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e CARKATH, ayant son si\u00E8ge \u00E0 1180 Uccle, Rue Copernic 6A, inscrite au registre des personnes morales sous le num\u00E9ro 0811.816.556, repr\u00E9sent\u00E9e par son repr\u00E9sentant permanent Monsieur Eric HALIOUA, pr\u00E9nomm\u00E9 ;"
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Fran\u00E7ois FONTAINE",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "SOCIETE FEDERALE DE PARTICIPATIONS ET D\u0027INVESTISSEMENT",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "4) ilarsoci\u00E9t\u00E9 anonyme de droit public SOCIETE FEDERALE DE PARTICIPATIONS ET D\u0027INVESTISSEMENT, en abr\u00E9g\u00E9 \u00AB S.F.P.I.x, pr\u00E9nomm\u00E9e, repr\u00E9sent\u00E9e par Monsieur Fran\u00E7ois FONTAINE, domicili\u00E9 \u00E0 6010 Charleroi, Avenue de l\u0027Europe 259, en qualit\u00E9 de repr\u00E9sentant permanent;"
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "TOUNSI Amel",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0808219836",
        "name": "NOSHAQ PARTNERS",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "5) iLa soci\u00E9t\u00E9 coop\u00E9rative NOSHAQ PARTNERS, ayant son si\u00E8ge \u00E0 Li\u00E8ge, rue Lambert-Lombard 3, inscrite au registre des personnes morales sous le num\u00E9ro 0808.219.836 repr\u00E9sent\u00E9e par son repr\u00E9sentant permanent Monsieur TOUNSI Amel, domicili\u00E9e \u00E0 Place Jean Gabin 1A, 1090 Jette, Belgique;"
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Sang Woo LEE",
        "address": null,
        "birth_date": null
      },
      "evidence_quote": "6) Monsieur Sang Woo LEE, domicili\u00E9 \u00E0 2013 Sun Mor Ave, Mountain View, CA 94040, USA;"
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "PRIEELS Jean Paul",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0829890923",
        "name": "JPP CONSULTING",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "7) la soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e \u00AB\u003C JPP CONSULTING \u00BB, ayant son si\u00E8ge \u00E0 1380 Lasne, Chemin du Gros Tienne 61, inscrite au registre des personnes morales sous le num\u00E9ro 0829.890.923, repr\u00E9sent\u00E9e par son repr\u00E9sentant permanent Monsieur PRIEELS Jean Paul, domicili\u00E9 \u00E0 1380 Lasne, Chemin du Gros Ti"
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Alain HERRERA",
        "address": null,
        "birth_date": null
      },
      "evidence_quote": "8) Monsieur HERRERA Alain, domicili\u00E9 \u00E0 75006 Paris (France), 77 Rue De Vaugirard, nomm\u00E9 en qualit\u00E9 d\u0027administrateur ind\u00E9pendant;"
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Mondher MAHJOUBI",
        "address": null,
        "birth_date": null
      },
      "evidence_quote": "9) Monsieur MAHJOUBI Mondher, domicili\u00E9 \u00E0 Corniche Pr\u00E9sident Kennedy 397, Res les Alpines, 13007 Marseille, France, nomm\u00E9 en qualit\u00E9 d\u0027administrateur ind\u00E9pendant."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0657.842.221",
    "name_full": "PDC LINE PHARMA",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Hugues WALLEMACQ",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0657842221",
        "name": "NOSHAQ PARTNERS",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2021-02-25",
      "evidence_quote": "A dater du 25 f\u00E9vrier 2021, Amel Tounsi remplacera Hugues WALLEMACQ en qualit\u00E9 de repr\u00E9sentant permanent de la SCRL NOSHAQ PARTNERS, Administrateur."
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Amel Tounsi",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0657842221",
        "name": "NOSHAQ PARTNERS",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2021-02-25",
      "evidence_quote": "A dater du 25 f\u00E9vrier 2021, Amel Tounsi remplacera Hugues WALLEMACQ en qualit\u00E9 de repr\u00E9sentant permanent de la SCRL NOSHAQ PARTNERS, Administrateur."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0657.842.221",
    "name_full": "PDC LINE PHARMA",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Mondher MAHJOUBI",
        "address": null,
        "birth_date": null
      },
      "evidence_quote": "A l\u0027unanimit\u00E9, les actionnaires de la soci\u00E9t\u00E9 ont \u00E9lu Monsieur Mondher MAHJOUBI au poste d\u0027administrateur;"
    },
    {
      "kind": "commissaris_renew",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Abdel SERGHINI",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "L\u0026S R\u00E9viseurs d\u0027entrepr\u00EDse SRL",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "A l\u0027unanimit\u00E9, les actionnaires de la soci\u00E9t\u00E9 ont renouvell\u00E9 le mandat de commissaire de L\u0026S R\u00E9viseurs d\u0027entrepr\u00EDse SRL, repr\u00E9sent\u00E9e par Abdel SERGHINI, en qualit\u00E9 de commissaire aux comptes pour les exercices comptables prenant fin les 31.12.2020, 31.12.2021 et 31.12.2022;"
    },
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Joanna TYREKIDIS",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "SCRL NOSHAQ PARTNERS",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2020-01-29",
      "evidence_quote": "A dater du 29 janvier 2020, Hugues WALLEMACQ remplacera Joanna TYREKIDIS en qualit\u00E9 de repr\u00E9sentant permanent de la SCRL NOSHAQ PARTNERS, Administrateur."
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Hugues WALLEMACQ",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "SCRL NOSHAQ PARTNERS",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2020-01-29",
      "evidence_quote": "A dater du 29 janvier 2020, Hugues WALLEMACQ remplacera Joanna TYREKIDIS en qualit\u00E9 de repr\u00E9sentant permanent de la SCRL NOSHAQ PARTNERS, Administrateur."
    },
    {
      "kind": "director_in",
      "role": "gedelegeerd_bestuurder",
      "person": {
        "rrn": null,
        "name": "Eric Halioua",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "CarKath SRL",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "CarKath SRL, Administrateur d\u00E9l\u00E9gu\u00E9 repr\u00E9sent\u00E9 par Eric Halioua, repr\u00E9sentant permanent"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0657.842.221",
    "name_full": "PDC LINE PHARMA",
    "legal_form": "SA"
  }
}

{
  "stage": null,
  "notary": {
    "name": "G\u00E9rard INDEKEU",
    "firm_city": null,
    "firm_name": "G\u00E9rard INDEKEU - Dimitri CLEENEWERCK de CRAYENCOUR",
    "office_city": "Bruxelles",
    "is_associated": true
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2020-07-28",
    "filing_date": null,
    "act_kind_objet": "Emission d\u0027un nouveau plan d\u0027options sur actions-Modification des statuts"
  },
  "decision": {
    "body": "bijzondere_algemene_vergadering",
    "act_date": "2020-05-26",
    "unanimous": true
  },
  "conversion": null,
  "detected_kind": "other",
  "report_waiver": null,
  "restructuring": {
    "parties": [
      {
        "kbo": "0657.842.221",
        "name": "PDC line Pharma",
        "role": "other",
        "address": "Tour GIGA (B34) - Avenue de l\u0027H\u00F4pital num\u00E9ro 11 \u00E0 4000 Li\u00E8ge",
        "is_foreign": false,
        "legal_form": "Soci\u00E9t\u00E9 Anonyme",
        "is_new_company": false,
        "jurisdiction_country": null
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [
      "7:180",
      "7:188"
    ],
    "is_cross_border": false,
    "is_silent_merger": false,
    "balance_basis_date": null,
    "exchange_ratio_text": null,
    "new_shares_issued_n": 10202,
    "real_estate_included": false,
    "patrimony_description": "\u00C9mission de 10 202 droits de souscription permettant l\u0027acquisition de nouvelles actions au prix de 184 \u20AC chacun. Ces droits sont attribu\u00E9s \u00E0 des membres du management, employ\u00E9s, consultants et administrateurs de la soci\u00E9t\u00E9 ou de ses filiales.",
    "equity_transferred_eur": null,
    "accounting_effective_date": null
  },
  "subject_company": {
    "kbo": "0657.842.221",
    "name_full": "PDC line Pharma",
    "legal_form": "Soci\u00E9t\u00E9 Anonyme"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "G\u00E9rard INDEKEU",
    "org_rep_person_name": null
  },
  "summary_narrative": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale extraordinaire des actionnaires de PDC line Pharma, r\u00E9unie le 26 mai 2020, a adopt\u00E9 \u00E0 l\u0027unanimit\u00E9 des voix la cr\u00E9ation d\u0027un nouveau plan d\u0027options sur actions, avec \u00E9mission de 10 202 droits de souscription \u00E0 184 \u20AC chacun. Les actionnaires ont renonc\u00E9 \u00E0 leur droit de souscription pr\u00E9f\u00E9rentielle. L\u0027assembl\u00E9e a \u00E9galement d\u00E9cid\u00E9 d\u0027augmenter le capital social sous condition suspensive d\u0027exercice des droits, et a modifi\u00E9 l\u0027article 19 des statuts pour aligner le r\u00E8glement de la pr\u00E9sidence du conseil d\u0027administration sur le pacte d\u0027actionnaires.",
  "co_filed_documents": [
    "exp\u00E9dition conforme de l\u0027acte",
    "procurations",
    "statuts coordonn\u00E9s",
    "rapport du R\u00E9viseur",
    "rapport sp\u00E9cial du Conseil d\u0027Administration"
  ],
  "detected_real_type": "other",
  "referenced_correction": null,
  "should_reroute_to_category": "capital_shares"
}

{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0657.842.221",
    "name_full": "PDC LINE PHARMA",
    "legal_form": "SA"
  }
}

{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0657.842.221",
    "name_full": "PDC LINE PHARMA",
    "legal_form": "SA"
  }
}

{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0657.842.221",
    "name_full": "PDC LINE PHARMA",
    "legal_form": "SA"
  }
}

{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0657.842.221",
    "name_full": "PDC LINE PHARMA",
    "legal_form": "SA"
  }
}

{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0657.842.221",
    "name_full": "PDC LINE PHARMA",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Fran\u00E7ois FONTAINE",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "SOCIETE FEDERALE DE PARTICIPATIONS ET D\u0027INVESTISSEMENT",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "Conform\u00E9ment \u00E0 la convention d\u0027actionnaires, l\u0027assembl\u00E9e d\u00E9cide de nommer sur proposition de la soci\u00E9t\u00E9 anonyme de droit public \u00AB SOCIETE FEDERALE DE PARTICIPATIONS ET D\u0027INVESTISSEMENT \u00BB, en abr\u00E9g\u00E9 S.F.P.I. \u00BB, un administrateur suppl\u00E9mentaire pour une dur\u00E9e de six ans et \u00E0 titre gratuit, \u00E0 savoir : "
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0657.842.221",
    "name_full": "PDC LINE PHARMA",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "zetel_transfer",
      "seat_type": "statutaire",
      "new_address": {
        "city": "Li\u00E8ge",
        "region": null,
        "street": "avenue de l\u0027H\u00F4pital",
        "country": "BE",
        "postcode": "4000",
        "box_number": "B34",
        "street_number": "11"
      },
      "old_address": {
        "city": "Li\u00E8ge",
        "region": null,
        "street": "All\u00E9e des Noisetiers",
        "country": "BE",
        "postcode": "4031",
        "box_number": null,
        "street_number": "2"
      },
      "effective_date": "2017-05-18",
      "evidence_quote": "Lors du conseil d\u0027administration qui s\u0027est tenu le 18 mai 2017, il a \u00E9t\u00E9 d\u00E9cid\u00E9 de d\u00E9placer, avec effet imm\u00E9diat, le si\u00E8ge social de la SA PDC Line Pharma \u00E0 l\u0027adresse suivante: Tour GIGA (B34), 11 avenue de l\u0027H\u00F4pital \u00E0 4000 Li\u00E8ge"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0657.842.221",
    "name_full": "PDC LINE PHARMA",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 19987.5,
      "currency": "EUR",
      "after_eur": 1331567.5,
      "delta_eur": 19987.5,
      "before_eur": 1311580.0,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2016-11-17",
      "evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide d\u0027augmenter le capital social \u00E0 concurrence de dix-neuf mille neuf cent quatre-vingt-sept euros cinquante cents (19.987,50 \u20AC) pour le porter d\u0027un million trois cent onze mille cing cent quatre-vingt euros (1.311.580,00 \u20AC) \u00E0 un million trois cent trente et un mille cinq cent soixante-sept euros cinquante cents (1.331.567,50 \u20AC), par apport en esp\u00E8ces",
      "contribution_type": "cash"
    },
    {
      "kind": "capital_increase",
      "amount": 1280012.5,
      "currency": "EUR",
      "after_eur": 2611580.0,
      "delta_eur": 1280012.5,
      "before_eur": 1331567.5,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2016-11-17",
      "evidence_quote": "L\u0027assembl\u00E9e d\u00E8cide d\u0027augmenter le capital social \u00E0 concurrence d\u0027un million deux cent quatre-vingt mille: douze euros cinquante cents (1.280.012,50 \u20AC) pour le porter d\u0027un million trois cent trente et un mille cing cent soixante-sept euros cinquante cents (1.331.567,50 \u20AC) \u00E0 deux millions six cent onze mille cinq cent quatre-vingt euros (2.611.580,00 \u20AC), sans cr\u00E9ation de nouvelles actions, par incorporation au capital de la totalit\u00E9 de la \u0022prime d\u0027\u00E9mission\u0022",
      "contribution_type": "cash"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0657.842.221",
    "name_full": "PDC LINE PHARMA",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "PRIEELS Jean Paul",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0829890923",
        "name": "JPP CONSULTING",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "La soci\u00E9t\u00E9 priv\u00E9e \u00E0 responsabilit\u00E9 limit\u00E9e \u00AB JPP CONSULTING \u00BB, ayant son si\u00E8ge social \u00E0 1380 Lasne, Chemin du Gros Tienne 61, inscrite au registre des personnes morales sous le num\u00E9ro 0829.890.923, repr\u00E9sent\u00E9e par son repr\u00E9sentant permanent Monsieur PRIEELS Jean Paul, domicili\u00E9 \u00E0 1380 Lasne, Chemin "
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "TYREKIDIS Joanna",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0808219836",
        "name": "SC-SPRL INVESTPARTNER",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "La SC-SPRL INVESTPARTNER ayant son si\u00E8ge social \u00E0 Li\u00E8ge, rue Lambert-Lombard 3, inscrite au registre des personnes morales sous le num\u00E9ro 0808 219 836 repr\u00E9sent\u00E9e par son repr\u00E9sentant permanent Madame TYREKIDIS Joanna, domicili\u00E9e \u00E0 4130 Esneux, Avenue Nandrin 35, est nomm\u00E9e sur proposition des actio"
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "HERRERA Alain",
        "address": null,
        "birth_date": null
      },
      "evidence_quote": "Monsieur HERRERA Alain, domicili\u00E9 \u00E0 75006 Paris (France), 77 Rue De Vaugirard, est nomm\u00E9 en qualit\u00E9 d\u0027administrateur ind\u00E9pendant."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0657.842.221",
    "name_full": "PDC LINE PHARMA",
    "legal_form": "SA"
  }
}

{
  "kind": "oprichting",
  "seat": "4031 Angleur, All\u00E9e des Noisetiers 2",
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "founders": [
    {
      "org": null,
      "kind": "natural_person",
      "person": {
        "dob": null,
        "name": "Laurent LEVY",
        "niss": null,
        "address": "Rue du Docteur Edmond Locard 126, 69005 Lyon (France)"
      },
      "share_class": "ordinaires",
      "partner_role": null,
      "holder_org_kbo": null,
      "holder_org_name": null,
      "contribution_type": "in_kind",
      "amount_paid_in_eur": 24600,
      "holder_person_name": "Laurent LEVY",
      "is_subscriber_only": false,
      "n_shares_subscribed": 20000,
      "amount_subscribed_eur": 24600,
      "is_anonymous_silent_partner": false
    },
    {
      "org": null,
      "kind": "natural_person",
      "person": {
        "dob": null,
        "name": "Jo\u00EBl PLUMAS",
        "niss": null,
        "address": "Rue de la Scierie 5, 38000 Grenoble (France)"
      },
      "share_class": "ordinaires",
      "partner_role": null,
      "holder_org_kbo": null,
      "holder_org_name": null,
      "contribution_type": "in_kind",
      "amount_paid_in_eur": 24600,
      "holder_person_name": "Jo\u00EBl PLUMAS",
      "is_subscriber_only": false,
      "n_shares_subscribed": 20000,
      "amount_subscribed_eur": 24600,
      "is_anonymous_silent_partner": false
    },
    {
      "org": null,
      "kind": "natural_person",
      "person": {
        "dob": null,
        "name": "Eric HALIOUA",
        "niss": null,
        "address": "Rue Copernic 6A, 1180 Uccle"
      },
      "share_class": "ordinaires",
      "partner_role": null,
      "holder_org_kbo": null,
      "holder_org_name": null,
      "contribution_type": "in_kind",
      "amount_paid_in_eur": 12300,
      "holder_person_name": "Eric HALIOUA",
      "is_subscriber_only": false,
      "n_shares_subscribed": 10000,
      "amount_subscribed_eur": 12300,
      "is_anonymous_silent_partner": false
    }
  ],
  "capital_eur": 61500,
  "subject_company": {
    "kbo": "0657.842.221",
    "name_full": "PDC line Pharma",
    "legal_form": "SNC"
  },
  "initial_directors": [],
  "incorporation_date": "2016-06-27",
  "post_incorporation_mandates": []
}